伊諾來富新型冠狀病毒抗原檢驗試劑

INTRODUCTION The ENNOLIFE COVID-19 Antigen Test employed magnetic beads and microfluidic technology in a sandwich immunoassay design that is used with ENNOLIFE Clinical Chemistry Analyzer for the detection of COVID-19 antigen (nucelocapsid protein or NP) producing 3 inspection reports in 30 minutes with accuracy up to 93.33%. (閱讀全文…)

Highly potent broad-spectrum therapeutic antibodies for COVID-19

This section briefly summarizes the preliminary results of our highly potent broad-spectrum therapeutic antibodies for COVID-19. The above figure outlines the development processing of our therapeutic antibodies for COVID-19. We first expressed the ECD domain of spike protein in trimer form as antigen and performed the bio-panning process to identify possible binders. (閱讀全文…)

Vstrip COVID-19 抗原快篩

INTRODUCTION Vstrip® COVID-19 Antigen Rapid Test is a rapid immunochromatographic assay that utilizes specific monoclonal antibodies to detect the nucelocapsid protein (NP) of SARS-CoV-2 virus in nasopharyngeal swab specimens, producing results in 10 minutes and at approximately 10% the cost of a PCR. (閱讀全文…)

Human Synthetic Antibody Libraries

For more than 25 protein antigens including cancer biomarkers, immune checkpoint molecular antigens, and important viral antigens, nearly 900 antibody hits have been initially screened from our antibody libraries.

認識安肽

安肽生醫科技股份有限公司於2018年4月成立於新竹竹北生醫園區，是一家專注於開發新型治療性抗體和蛋白質藥物的新藥研發公司。自2020年7月起，總部則移至台灣新竹科學園區矽導中心。主要使命是為免疫治療和感 […]

核心技術

安肽生醫構建了高複雜度的抗體庫和蛋白庫，並為蛋白與抗體生產和抗體篩選建置了高效率的平台。我們也專注於開發新一代多價抗體 Neobody™，它能增強我們免疫系統檢測和破壞腫瘤細胞的能力，並避免相關副作用。

專業服務

We provide the following services for academic institutions and pharmaceutical companies. Please feel free to contact us if you need any further information!

伊諾來富 新型冠狀病毒抗原檢驗試劑